Schedule 13G ownership disclosure

Silence Therapeutics plc

Ordinary Shares, par value GBP 0.05 per share (the "Shares") · CUSIP: G8128Y157

Event date: 2024-12-31

Filing-level shares
10,713,627
Percent of class
7.6%
  • Lombard Odier Asset Management (USA) Corp

    Shares: 10,713,627 · Class: 7.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000908834-25-000064
Form type
SCHEDULE 13G/A
Filer
Lombard Odier Asset Management
CIK
CIK 1491719
Filed
Feb 11, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub